We are live on ! Find out more
MD icon

Pediatrix Medical

227 hedge funds and large institutions have $659M invested in Pediatrix Medical in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 73 increasing their positions, 80 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

237% more call options, than puts

Call options by funds: $165K | Put options by funds: $49K

48% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 33

7% more funds holding

Funds holding: 213227 (+14)

2.63% more ownership

Funds ownership: 101.12%103.74% (+2.6%)

9% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 80

23% less capital invested

Capital invested by funds: $853M → $659M (-$194M)

Holders
227
Holders Change
+14
Holders Change %
+6.57%
% of All Funds
3.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
49
Increased
73
Reduced
80
Closed
33
Calls
$165K
Puts
$49K
Net Calls
+$116K
Net Calls Change
-$287K
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
51
Jane Street
New York
$1.49M +$1.63M +196,951 New
Public Sector Pension Investment Board (PSP Investments)
52
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.38M +$84.8K +10,253 +6%
Two Sigma Investments
53
Two Sigma Investments
New York
$1.31M +$773K +93,424 +116%
Nordea Investment Management
54
Nordea Investment Management
Sweden
$1.3M -$270K -32,662 -16%
SEI Investments
55
SEI Investments
Pennsylvania
$1.27M -$130K -15,719 -9%
Walleye Capital
56
Walleye Capital
New York
$1.27M +$1.39M +167,587 New
RA
57
Royce & Associates
New York
$1.25M +$120K +14,506 +10%
Axa
58
Axa
France
$1.25M +$79.9K +9,664 +6%
Connor, Clark & Lunn Investment Management (CC&L)
59
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.24M +$475K +57,412 +54%
Federated Hermes
60
Federated Hermes
Pennsylvania
$1.23M -$535K -64,702 -28%
Swiss National Bank
61
Swiss National Bank
Switzerland
$1.19M
Two Sigma Advisers
62
Two Sigma Advisers
New York
$1.11M -$52.9K -6,400 -4%
Millennium Management
63
Millennium Management
New York
$1.11M +$1.06M +127,542 +673%
SC
64
Sasco Capital
Connecticut
$1.09M +$236K +28,480 +25%
New York State Teachers Retirement System (NYSTRS)
65
New York State Teachers Retirement System (NYSTRS)
New York
$1.03M -$4.14K -500 -0.4%
Marshall Wace
66
Marshall Wace
United Kingdom
$1.01M +$687K +83,082 +163%
WG
67
Winton Group
United Kingdom
$985K +$273K +33,057 +34%
BCC
68
Bridge City Capital
Oregon
$974K +$2.13K +258 +0.2%
Susquehanna International Group
69
Susquehanna International Group
Pennsylvania
$973K +$866K +104,646 +432%
Voloridge Investment Management
70
Voloridge Investment Management
Florida
$941K -$1.87M -226,332 -64%
American Century Companies
71
American Century Companies
Missouri
$939K +$124K +15,023 +14%
GCP
72
GSA Capital Partners
United Kingdom
$826K +$602K +72,718 +198%
HF
73
HRT Financial
New York
$822K +$901K +108,900 New
Citigroup
74
Citigroup
New York
$798K +$338K +40,853 +63%
Verition Fund Management
75
Verition Fund Management
Connecticut
$726K +$677K +81,880 +571%

MD Hedge Fund Activity: Q2 2024 in Review

227 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2024, worth a combined $659M — down 23% from $853M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new MD positions and 33 closed out — a net gain of 16 holders — while 73 added to existing stakes and 80 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $59.9M. The largest seller was Pacer Advisors, exiting entirely with an estimated $52.4M sold.

  • 227 institutional investors held Pediatrix Medical (MD) as of Q2 2024, up from 213 in Q1 2024.
  • Funds reported $659M of Pediatrix Medical stock for Q2 2024, down 23% quarter-over-quarter.
  • 49 funds opened new Pediatrix Medical positions in Q2 2024 and 33 closed out, a net change of +16 holders.
  • The largest Pediatrix Medical buyer in Q2 2024 was Rubric Capital Management (New York), an estimated $59.9M added.
  • The largest Pediatrix Medical seller in Q2 2024 was Pacer Advisors, an estimated $52.4M sold.

Based on aggregated 13F filings for Q2 2024.